Solventum Corp reported $173.53M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
Align Technology USD 71.62M 133K Mar/2026
Baxter International USD 516.45M 2.17M Mar/2026
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Cencora USD 194.52M 584.21K Dec/2025
Dexcom USD 385.9M 1.1M Mar/2026
Insulet USD 69.26M 1.08M Mar/2026
Solventum Corp USD 173.53M 40.79K Mar/2026
West Pharmaceutical Services USD 70.9M 1.1M Mar/2026
Zimmer Biomet Holdings USD 195.5M 2.68M Mar/2026